Table 1 Univariate and multivariate analyses of baseline variables associated with deaths from infection versus deaths not due to infection.

From: The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial

Variable

Deaths from infection (%)

Deaths not due to infection (%)

Odds ratio

95% confidence levels

P-value

A. Univariate analysis: all trial patients with a known cause of death (n = 600)

≥2 lines of treatment

194/258 (75)

231/342 (68)

1.46

1.01–2.09

0.04

Winter season

149/258 (58)

166/342 (49)

1.45

1.05–2.01

0.03

BRAF mutation

19/175 (11)

9/225 (4)

2.92

1.29–6.63

0.01

FBXW7 mutation

8/175 (5)

2/225 (1)

5.34

1.12–25.48

0.04

NRAS mutation

9/175 (5)

1/225 (0.4)

12.14

1.52–96.79

0.02

XPO1 mutation

17/175 (10)

9/225 (4)

2.58

1.12–5.94

0.03

B. Univariate analysis: patients with a known cause of death and gene mutation data (n = 400)

11q deletion

47/162 (29)

40/209 (19)

1.73

1.06–2.80

0.03

BRAF mutation

19/175 (11)

9/225 (4)

2.92

1.29–6.63

0.01

FBXW7 mutation

8/175 (5)

2/225 (1)

5.34

1.12–25.48

0.04

NRAS mutation

9/175 (5)

1/225 (0.4)

12.14

1.52–96.79

0.02

XPO1 mutation

17/175 (10)

9/225 (4)

2.58

1.12–5.94

0.03

C. Multivariate analysis: patients with a known cause of death and gene mutation data (n = 400)

11q deletion

  

1.79

1.09–2.94

0.02

BRAF mutation

  

3.22

1.33–7.80

0.01

NRAS mutation

  

10.78

1.31–88.43

0.03

XPO1 mutation

  

2.49

1.01–6.12

0.05